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Summary
A major question in plant biology is how phytohormone pathways interact. Here, we explore the
mechanism by which cytokinins and brassinosteroids affect ethylene biosynthesis. Ethylene
biosynthesis is regulated in response to a wide variety of endogenous and exogenous signals,
including the levels of other phytohormones. Cytokinins act by increasing the stability of a subset
of ACC synthases, which catalyze the generally rate-limiting step in ethylene biosynthesis. The
induction of ethylene by cytokinin requires the canonical cytokinin two-component response
pathway, including histidine kinases, histidine phosphotransfer proteins and response regulators. The
cytokinin-induced myc–ACS5 stabilization occurs rapidly (<60 min), consistent with a primary
output of this two-component signaling pathway. We examined the mechanism by which another
phytohormone, brassinosteroid, elevates ethylene biosynthesis in etiolated seedlings. Similar to
cytokinin, brassinosteroid acts post-transcriptionally by increasing the stability of ACS5 protein, and
its effects on ACS5 were additive with those of cytokinin. These data suggest that ACS is regulated
by phytohormones through regulatory inputs that probably act together to continuously adjust
ethylene biosynthesis in various tissues and in response to various environmental conditions.
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Introduction
Ethylene is a gaseous plant hormone that is involved in many growth and developmental
processes, including germination, abscission, senescence, plant defense and fruit ripening
(Abeles et al., 1992). Ethylene is derived from the amino acid methionine, and is produced in
three steps: conversion of methionine to Ado-met by S-adenyl methionine synthetase,
conversion of Ado-met to ACC by ACC synthase (ACS), and conversion of ACC to ethylene
by ACC oxidase (ACO) (Yang and Hoffman, 1984). The conversion of Ado-met to ACC by
ACS is the first committed step and is generally the rate-limiting step in this pathway (Adams
and Yang, 1979; Yang and Hoffman, 1984). The ACS family in Arabidopsis consists of nine
proteins, of which eight have ACS activity as homodimers (Tsuchisaka and Theologis,
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2004a; Yamagami et al., 2003). These proteins form homodimers and heterodimers with
distinct enzyme kinetics (Tsuchisaka and Theologis, 2004a). The protein sequence of the
catalytic core is highly conserved, but the C-terminal region of ACS proteins is divergent and
the proteins may be sub-divided into three groups on that basis: type 1 ACS proteins have the
longest C-terminus with a single putative calcium-dependent protein kinase (CDPK)
phosphorylation site and three mitogen-activated protein kinase (MAPK) phosphorylation
sites, type 2 ACS proteins have an intermediate length C-terminus containing a single putative
CDPK phosphorylation site, and type 3 ACS proteins have a very short C-terminus and no
predicted kinase phosphorylation sites (Chae and Kieber, 2005; Liu and Zhang, 2004; Sebastià
et al., 2004; Tatsuki and Mori, 2001; Yoshida et al., 2005).
The ACS genes are transcriptionally regulated both developmentally and in response to
environmental stimuli (Tsuchisaka and Theologis, 2004b; Wang et al., 2005; Yamagami et
al., 2003). Recent evidence suggests that an important component of the regulation of ACS
and ethylene biosynthesis occurs post-transcriptionally by stabilization of the ACS proteins
(Argueso et al., 2007; Chae and Kieber, 2005; Chae et al., 2003; Liu and Zhang, 2004; Tatsuki
and Mori, 2001; Wang et al., 2004). Phosphorylation of the MAPK sites in type 1 ACSs
increases the stability of the protein and thus increases ethylene production (Joo et al., 2008;
Liu and Zhang, 2004). Mutations in the C-terminal region of type 2 ACSs (eto2 and eto3 in
ACS5 and ACS9, respectively) increase the stability of the protein and increase ethylene
production in the dark (Chae et al., 2003; Joo et al., 2008; Vogel et al., 1998b). The type 2
ACSs are degraded by the 26S proteasome, a process mediated by an E3 ligase in a C-terminus-
dependent manner (Wang et al., 2004; Yoshida et al., 2005, 2006). ETO1 is an adaptor BTB-
TPR (broad-complex, tramtrack, bric-a-brac/tetratricopeptide repeat) protein that is a
component of this E3 ligase complex, and eto1 hypomorphic mutations result in the over-
production of ethylene (Gingerich et al., 2005; Guzman and Ecker, 1990; Pintard et al.,
2004; Wang et al., 2004; Weber et al., 2004). Loss-of-function mutations in RUB (related-to-
ubiquitin) components of the E3-mediated protein degradation pathway, the rub1 rub2 double
mutant, the rce1 (RUB1 conjugating enzyme) and ecr1 (E1-conjugating enzyme-related 1)
mutants, display triple responses in the absence of exogenous ethylene, and some phenotypes
in these mutants are dependent on the ethylene perception pathway, indicating that additional
components of the E3 ligase pathway are involved in regulating ethylene biosynthesis (Bostick
et al., 2004; Larsen and Cancel, 2004; Woodward et al., 2007).
Several hormones are known to elevate ethylene biosynthesis, including auxins, cytokinins
and brassinosteroids (Arteca and Arteca, 2008; Woeste et al., 1999a; Yi et al., 1999). Auxin
treatment results in an increase in the level of several ACS transcripts, while cytokinin has been
shown to increase ACS5 protein stability (Abel et al., 1995; Chae et al., 2003; Liang et al.,
1992; Tsuchisaka and Theologis, 2004b; Vogel et al., 1998a; Wang et al., 2004; Woeste et
al., 1999a,b; Yamagami et al., 2003). Brassinosteroids have been shown to increase VrACS7
transcripts in mung bean, although the mechanism by which brassinosteroids increase ethylene
synthesis in Arabidopsis has not been studied.
The cytokinin-signaling pathway has been elucidated, and involves four groups of proteins that
show partial functional redundancy: Arabidopsis histidine kinases (AHK), Arabidopsis
histidine phosphotransfer proteins (AHP), type B Arabidopsis response regulators (ARRs) and
type A ARRs (Kakimoto, 2003; To and Kieber, 2008). The three cytokinin receptor AHKs
bind cytokinin and transmit the signal to the AHPs via phosphorylation (To and Kieber,
2008). The AHPs then phosphorylate the type B and type A ARRs, which act as positive and
negative elements, respectively, in cytokinin signaling. Cytokinin response factors (CRFs) are
downstream transcription factors that are transcriptionally up-regulated in response to
cytokinin (Rashotte et al., 2003, 2006).
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Brassinosteroid (BR) is a plant hormone that is implicated in germination, stem elongation,
leaf growth, fertility and response to disease and stress (reviewed by Belkhadir et al., 2006;
Fujioka and Yokota, 2003; Li and Jin, 2007). Exogenous brassinolide increases ethylene
synthesis in etiolated Arabidopsis seedlings, in inflorescence stems in conjuction with auxin,
and in mung bean hypocotyls with auxin or cytokinin (Arteca and Arteca, 2008; Woeste et
al., 1999a; Yi et al., 1999). BR is perceived by the BRI1 receptor, a leucine-rich receptor-like
kinase (LRR-RLK) that can dimerize with and phosphorylate BAK1 (Belkhadir et al., 2006;
Fujioka and Yokota, 2003; Li and Jin, 2007). There are two other BRI1-like genes (BRLs) in
Arabidopsis that can also act as BR receptors (Cano-Delgado et al., 2004; Li, 2003; Zhou et
al., 2004). BRI1 transmits the signal to inactivate BIN2 (BR-insensitive 2), a GSK3-like kinase
that is a negative regulator of the BR pathway. BIN2 phosphorylates the transcription factors
BES1 (BRI1-EMS-suppressor 1) and BZR1 (brassinazole-resistant 1), which promotes their
degradation, and inhibits the DNA-binding activity of BES1.
Here, we investigate the mechanism by which cytokinin and BR increase ethylene biosynthesis.
We examine the impact of cytokinin-signaling mutants on ethylene biosynthesis and the
kinetics of cytokinin-mediated ACS protein stability, and investigate points of intersection
between cytokinin, BR and ethylene biosynthesis.
Results
Cytokinin and BR both increase ethylene biosynthesis, but BR does not induce a full triple
response
We examined whether elevated ethylene in response to cytokinin and BR resulted in a triple
response, the morphology that dark-grown Arabidopsis seedlings display in the presence of
ethylene. Application of cytokinin increases ethylene biosynthesis and does induce a triple
response (Figure 1) (Vogel et al., 1998a). However, the increase in ethylene production in
response to BR does not result in seedlings displaying complete triple-response morphology.
In particular, although growth on BR does result in a shortened and thickened hypocotyl, the
exaggerated curvature of the apical hook is absent, and the lengths of the root and hypocotyl
are not reduced as much as in ACC or benzyladenine (BA)-treated seedlings. Furthermore, the
hypocotyl displays irregular spiral growth (Figure 1). Therefore, in addition to increasing
ethylene production, BR has other effects on seedling morphology and prevents a complete
triple response. Growth in the presence of either BA or BR results in some shortening of the
hypocotyl in the strong ethylene-insensitive mutant ein2−5, and, in the case of BR, the ein2
−5 seedlings display an irregular spiral-hypocotyl phenotype (Figure 1). These data indicate
that both cytokinin and BR have effects on etiolated seedling hypocotyl growth, independent
of ethylene. Measurement of ethylene levels confirmed that exogenous cytokinin and BR
increase ethylene production in etiolated seedlings (Figure 2a) (Vogel et al., 1998a;Woeste et
al., 1999a).
Cytokinin perception pathway mutants show decreased cytokinin-induced ethylene
biosynthesis
We examined whether cytokinin induction of ethylene biosynthesis required the canonical two-
component phospho-relay response pathway, and whether there is specificity for this response
within the gene families that encode the proteins involved in each step of the pathway. To this
end, loss-of-function cytokinin-signaling mutants for each step of the signaling pathway were
examined for ethylene production in response to cytokinin.
We first examined the cytokinin-receptor double mutants ahk2,3, ahk2,4 and ahk3,4. In the
absence of cytokinin, ahk double mutants produce amounts of ethylene comparable to those
produced by wild-type seedlings (Figure 2b). ahk2,4 and ahk3,4 mutants show reduced
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cytokinin-mediated induction of ethylene biosynthesis, indicating that these receptors are
required for this process. The double mutants with loss of function of ahk4 have lower ethylene
responses to cytokinin, indicating that AHK4 is probably the greatest primary contributor to
ethylene biosynthesis in response to cytokinin. We were unable to measure ethylene
biosynthesis in the ahk2,3,4 triple mutant as it is sterile.
The AHPs function redundantly in various cytokinin responses, including hypocotyl elongation
in the dark, which is known to be partially mediated by ethylene (Cary et al., 1995; Hutchison
et al., 2006; Vogel et al., 1998b). To test whether the AHPs are involved in cytokinin up-
regulation of ethylene biosynthesis, we examined the ahp1,2,3 and ahp1,2,3,4 mutants. In the
absence of exogenous cytokinin, both multiple loss-of-function mutants produced less ethylene
than the wild-type (Figure 2c). This probably reflects the effect of endogenous cytokinin in
regulating ethylene biosynthesis in wild-type seedlings, as these mutant displays a stronger
reduced cytokinin function phenotype than any of the double receptor mutants (Hutchison et
al., 2006). In response to cytokinin, the ahp1,2,3 and ahp1,2,3,4 mutants displayed greatly
reduced induction of ethylene, indicating that AHPs are necessary for transduction of the signal
for cytokinin induction of ethylene biosynthesis.
We also examined disruption of the type A ARR genes, which encode negative regulators of
cytokinin signaling (To et al., 2004). Ethylene production from wild-type and arr3,4,5,6,8,9
mutant seedlings was measured in response to increasing concentrations of cytokinin, ranging
from 10 nM to 50 μM. The arr3,4,5,6,8,9 mutant seedlings produced an elevated level of ethylene
in the absence of exogenous cytokinin, probably due to a heightened response to endogenous
cytokinin (Figure 2e). This multiple type A ARR mutant also produced more ethylene than the
wild-type in response to all levels of cytokinin tested (Figure 2e), which is consistent with the
hypersensitivity of this mutant in other response assays (To et al., 2004).
The type B ARRs are transcription factors that belong to a subgroup previously shown to be
involved in cytokinin signaling (Mason et al., 2004). Of the 11 type B ARRs, we tested the
arr1, arr2, arr10 and arr12 single mutants as well as the quadruple arr 1,2,10,12 mutant for
their impact on ethylene biosynthesis (Mason et al., 2005; Rashotte et al., 2006). Consistent
with the response in other assays, the arr1,2,10,12 mutant showed a marked decrease in the
elevation of ethylene in response to cytokinin (Figure 2d). Neither the basal or cytokinin-
induced levels of ethylene biosynthesis were affected in any of the single mutants tested, except
arr1, which was similar to the arr1,2,10,12 quadruple mutant. This suggests that ARR1 is the
primary type B ARR mediating this response.
The final pathway components that we tested were the CRFs, of which there are six in
Arabidopsis. Two triple mutants crf1,2,5 and crf2,3,6 have previously been shown to alter
cytokinin-regulated transcription (Rashotte et al., 2006). The triple mutants showed no changes
in ethylene biosynthesis, indicating that the CRFs are not required for ethylene induction by
cytokinin.
BR increases the half-life of ACS5 protein
To determine whether BR increases ethylene biosynthesis via changes in ACS5 stability, we
examined the half-life of ACS5 protein in a dexamethasone (Dex)-inducible myc-tagged
system (Chae et al., 2003). Seedlings were grown on a low level of Dex to induce near-
endogenous levels of ACS5 protein, and were then treated with either 0.1 μM BR or a carrier
control. Cycloheximide was then applied to inhibit de novo protein synthesis, and the turnover
of the myc–ACS5 fusion protein was examined by Western blotting (Figure 3a). ACS5 protein
has a half-life of 15−30 min (Chae et al., 2003; Spanu et al., 1994). Similar to cytokinin, BR
treatment caused a marked decrease in myc–ACS5 protein degradation. Although there is a
band at 60 min in the control that is more intense than neighboring bands, this is most likely
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the result of variations in the low level of protein induced in at this concentration of Dex; several
independent blots support this conclusion (e.g. Figure S1). These results indicate that BR
elevates ethylene biosynthesis at least partly through an increase in the stability of the ACS5
protein, although BR may also regulate ethylene through changes in transcription. Indeed,
examination of public microarray data suggests a 3.7-fold induction of ACS5 in response to
brassinolide in Arabidopsis (Zimmermann et al., 2004).
Kinetics of cytokinin stabilization of ACS5 protein
We have shown that cytokinin induction of ethylene biosynthesis is mediated via the
components of the known cytokinin-signaling pathway, and previous studies have indicated
that this occurs through stabilization of ACS5 protein (Chae et al., 2003). We examined the
kinetics of cytokinin-induced stabilization of the ACS5 protein in 4-day-old etiolated seedlings
(Figure 3c). In the control treatment, there is a transient increase in protein at 1 h, probably due
to increased stress on the seedling when moved to a liquid environment. Cytokinin-treated
seedlings clearly show further increased levels of steady-state ACS5 after 1 h, and this elevated
level persists until at least 26 h after cytokinin treatment. This time frame is consistent with an
early transcriptional response to cytokinin or a direct output of the signaling pathway.
Cytokinin and BR stabilize multiple type 2 ACSs
ACS proteins fall into three classes, based primarily on the presence or absence of regulatory
phosphorylation sites in the C-terminal domain. We have shown that cytokinin and BR both
up-regulate ethylene biosynthesis, at least in part through stabilization of ACS5 protein, a type
2 ACS. We examined whether the steady-state levels of ACS9, the type 2 ACS most closely
related to ACS5, were elevated in response to BA and brassinolide (Figure 4). Similar to ACS5,
ACS9 protein levels increase in response to both BA and brassinolide, suggesting that the effect
of cytokinin and BR is not specific for ACS5, but rather may be a general feature of type 2
ACSs. The effect of BA and brassinolide on protein stability was additive for both ACS5 and
ACS9. This is consistent with measurements of ethylene biosynthesis in which the effects of
BA and cytokinin are additive (Figure 2a) (Woeste et al., 1999a). This suggests that the two
hormones act through distinct targets on these ACS proteins.
The C-terminal domain of ACS5 and ACS9 is important in regulation of the stability of the
proteins (Chae et al., 2003; Wang et al., 2004; Yoshida et al., 2006). We examined whether
mutations in these C-termini affect the response to cytokinin and BR. Both ACS5eto2 and
ACS9eto3 are still stabilized by the hormones, indicating that these C-terminal mutations do
not disrupt the mechanism for this stabilization. It is possible that these mutations do not
completely abrogate the C-terminal regulatory function.
Discussion
Ethylene biosynthesis is highly regulated by multiple exogenous and endogenous inputs. A
primary point of regulation is control of the level and activity of the ACS enzymes. This key
enzyme is encoded by a multigene family that is subject to multiple layers of control that act
in concert to precisely mediate the level of ethylene produced by a cell in a given situation.
The first layer of control is regulation of transcription of the various ACS genes. A large number
of regulatory inputs, including brassinosteroid, auxin, wounding, anoxia and developmental
signals such as ripening and floral senescence, act at least in part by regulating the transcription
of distinct subsets of ACS genes (Argueso et al., 2007). A second level of control relates to
the diverse enzymatic properties of the large number of homo- and heterodimers that potentially
can form in different cells from the various ACS isoforms (Tsuchisaka and Theologis,
2004a). This can alter the amount of ethylene produced from the varying levels of S-adenyl
methionine substrate that may be present at any given time in a cell. Here, we explored a third
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regulatory input into ethylene biosynthesis, regulation of the stability of ACS protein in
response to other hormonal cues.
BR increases ethylene biosynthesis and does so by stabilizing ACS protein
BR treatment results in an increase in ethylene biosynthesis (Woeste et al., 1999a), and this
ethylene probably plays an important role in the many effects of BR on plant growth and
development. This is clearly shown by the growth of etiolated seedlings in the presence of BR
(Figure 1), for which there are ethylene-dependent and ethylene-independent effects. For
example, BR has been shown to promote cell elongation in hypocotyls in the light; if dark-
grown seedlings respond similarly to BR, then this effect would be counteracted by the action
of the elevated ethylene; thus the elongation of the hypocotyl in the presence of BR is the
summation of these two counteracting forces (De Grauwe et al., 2005; Fujioka and Yokota,
2003). In addition, BR causes spiral growth of the hypocotyl that is independent of ethylene.
Finally, BR promotes opening of the apical hook while ethylene causes an exaggeration in its
curvature.
We showed that ACS5 protein was stabilized in response to BR, suggesting that, like cytokinin,
BR increases ethylene synthesis by post-transcriptional regulation of ACS5. However, our
results also indicate an effect of BR on ACS transcription. Public transcriptome data indicate
that both ACS5 and ACS6 transcripts are slightly elevated (approximately 3.5-fold) in response
to brassinolide, and studies in mung bean indicate that VrACS7 is regulated transcriptionally
by BR (Yi et al., 1999; Zimmermann et al., 2004). Similarly, in etiolated seedlings, BR
treatment results in increase of ACS5 transcript levels (M.H. and J.J.K., unpublished results).
Thus, similar to cytokinin, BR has an effect on the transcription of ACS genes, but also acts
by increasing ACS protein stability.
The turnover of the three classes of ACS proteins appears to be regulated through distinct
mechanisms. For example, a pathogen-activated MAP kinase has been shown to phosphorylate
specifically type 1 ACSs (Joo et al., 2008; Liu and Zhang, 2004). The ETO1 protein is involved
in turnover specifically of type 2 ACS proteins (Wang et al., 2004; Yoshida et al., 2005,
2006), and cytokinin appears to act by increasing the stability of type 2 ACS proteins (Chae
et al., 2003). Here we show that BR also increases the stability of two type 2 ACS proteins.
Genetic and molecular analyses have demonstrated a role for the C-terminus of both type 1
and type 2 ACS proteins in targeting the respective proteins for rapid degradation. A simple
model suggests that BR and cytokinin act by inhibiting this C-terminus-dependent targeting.
However, surprisingly, both hormones still increase the stability of the eto2 and eto3 versions
of ACS proteins. Thus, the eto2 and eto3 mutations reduce, but do not eliminate interaction
with ETO1, and the eto3 mutant produces a normal BR-induced ethylene response (Woeste et
al., 1999b; Christians et al., 2008).
Cytokinin-induced ACS stabilization requires type B ARR transcription factors
We determined that the cytokinin signal that results in the stabilization of ACS5 passes through
the canonical cytokinin two-component pathway. We also found that the type B response
regulator ARR1 is necessary for the cytokinin-induced ethylene response. As type B ARRs
mediate transcriptional responses to cytokinin, this suggests that the action of cytokinin in
stabilizing ACS5 acts through altered transcription of a regulatory input. As the alteration of
ACS5 protein stability occurs fairly rapidly in response to cytokinin, it is likely that this
regulatory input is a primary target of cytokinin-activated ARR1. These data indicate that this
input is the primary type B ARR that mediates the response to cytokinin in the stabilization of
ACS5. Furthermore, basal ethylene biosynthesis is altered in several of the cytokinin-signaling
mutants, suggesting that endogenous cytokinin is important in regulating the level of ethylene
biosynthesis.
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A model summarizing the above data is shown in Figure 5. Type 2 ACSs are ubiquitinated by
E3 ligase containing an ETO1 component, and targeted to and degraded by the 26S proteasome.
This targeting is reduced by mutations in the C-terminus of the ACS protein, and by cytokinin
or brassinosteroid stabilization. Cytokinin stabilization occurs through the cytokinin-signaling
pathway: AHK dimers perceive the signal and phosphorylate AHPs, which in turn
phosphorylate type A ARRs and type B ARR1. The former negatively regulate both the
cytokinin-signaling pathway and ethylene biosynthesis, while the latter is necessary for
ethylene production.
Conclusions
ACS enzymes are encoded by a moderately large gene family, which is regulated by multiple
distinct transcriptional and post-transcriptional inputs. This allows exquisite control of ethylene
biosynthesis in plants in various developmental and environmental contexts. Here we highlight
two such regulatory inputs, cytokinin and BR. The data suggest that both hormones act to
stabilize type 2 ACS proteins. The precise nature of how cytokinin and BR stabilize ACS
protein awaits further study.
Experimental procedures
Plant materials and growth conditions
Unless stated otherwise, all wild-type controls were Col-0. The mutants used were ahk2−7,
ahk3−3, cre1−12 (ahk4 allele), arr1−3, 2−2, 10−2, 12−1, ahp2,3,5, arr3,4,5,6,8,9, crf1,2,5,
crf2,3,6 and ein2−5, and various combinations thereof (Mason et al., 2005; Rashotte et al.,
2006) (Hutchison et al., 2006; To et al., 2004). The ransgenic lines used were Dex-inducible
myc-tagged ACS5, ACS5eto2 (Chae et al., 2003), ACS9 and ACS9eto3. The coding region of
ACS9 was amplified from cDNA of wild-type and eto3, fused to a 6 × myc cassette, and then
cloned into the binary GVG vector pTA7002 (Aoyama and Chua, 1997). Col plants were
transformed with the plasmids by the floral dip method (Clough and Bent, 1998), and
transformants were selected on MS medium containing hygromycin. T2 seedlings for lines that
expressed the myc-tagged proteins at low levels in an inducible manner were grown on MS
medium containing 10 nM Dex screen. Seeds were sterilized and plated on 1 × MS/1% sucrose/
0.4% agar medium. The plates were incubated at 4°C for 5 days in the dark and then incubated
in the light for 4−6 h at room temperature. Plates were then moved to a 22°C dark chamber for
4 days. All cytokinin treatments comprised 5 μM benzyladenine from a 5 mM stock in 100%
DMSO, all BR treatments comprised 100 nM brassinolide from 100 μM stock in 80% ethanol,
all ACC treatments comprised 5 μM ACC from 25 mM stock in 100% DMSO, and all controls
comprised appropriate carrier added to MS. Dex treatment for the myc–ACS5 line was with
15 nM alone or 8 nM with BR, 30 nM for ACS9, 10 nM for ACS5eto2 and 40 nM Dex for
ACS9eto3.
Gas chromatography measurements
Seeds were sterilized using chlorine gas sterilization (100 ml bleach + 3 ml HCl in a 6 l closed
chamber for approximately 4 h), and 40−80 seeds in 0.4% agar were aliquoted into 3 ml 1 ×
MS/1% sucrose medium in 22 ml gas chromatography vials. Vials were cold-treated for 5 days
at 4°C in the dark, then incubated in the light for 4−6 h at room temperature, and then incubated
in the 22°C dark for 4 days. For cytokinin mutant experiments, vials were capped at day 3; all
others were capped when moved to 22°C. After growth at 22°C, the accumulated ethylene was
measured by gas chromatography as described previously (Vogel et al., 1998b). All genotypes
and treatments are represented by at least three vials each.
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Proteins were extracted from 4-day-old etiolated seedlings in two volumes of 6 × SDS buffer,
and ground with a mini-pestle. Extracts were incubated at 95°C for 3 min and at room
temperature for 5 min, and then centrifuged for 3 min at room temperature at 16 000 g in a
microcentrifuge (Eppendorf, http://www.eppendorf.com). Western analysis was performed
essentially as described previously (Chae et al., 2003).
Half-life experiment
Seedlings were grown on 15 nM Dex or 100 nM brassinolide plus 8 nM Dex in 1 × MS/1% sucrose/
0.4% agar under the standard growth conditions for etiolated seedlings described above. Four-
day-old etiolated seedlings were washed twice for 7 min in liquid 1 × MS and then moved to
individual tubes containing 200 μM cycloheximide in 1 × MS liquid. A subset of seedlings was
then extracted for the time 0 control, or samples were incubated for various times before
proteins were extracted.
Acknowledgments
This work was supported by a National Science Foundation grant (MCB0541973) to J.J.K. We would like to thank
Fernando Ferreira, Jennifer To and Jayson Punwani for editing and discussion of the manuscript, as well as Eric
Schaller (Dartmouth College, Department of Biological Sciences, New Hampshire) for germplasm and insightful
discussions.
References
Abel S, Nguyen MD, Chow W, Theologis A. ACS4, a primary indoleacetic acid-responsive gene encoding
1-aminocyclopropane-1-carboxylate synthase in Arabidopsis thaliana. J. Biol. Chem
1995;270:19093–19099. [PubMed: 7642574]
Abeles, FB.; Morgan, PW.; Saltveit, ME, Jr. Ethylene in Plant Biology. Vol. 2nd edn.. Academic Press
Inc.; San Diego, CA: 1992.
Adams DO, Yang SF. Ethylene biosynthesis: identification of 1-aminocyclopropane-1-carboxylic acid
as an intermediate in the conversion of methionine to ethylene. Proc. Natl. Acad. Sci. U.S.A
1979;76:170–174. [PubMed: 16592605]
Aoyama T, Chua NH. A glucocorticoid-mediated transcriptional induction system in transgenic plants.
Plant J 1997;11:605–612. [PubMed: 9107046]
Argueso CT, Hansen M, Kieber JJ. Regulation of ethylene biosynthesis. J. Plant Growth Regul
2007;26:92–105.
Arteca RN, Arteca JM. Effects of brassinosteroid, auxin, and cytokinin on ethylene production in
Arabidopsis thaliana plants. J. Exp. Bot 2008;59:3019–3026. [PubMed: 18583350]
Belkhadir Y, Wang X, Chory J. Brassinosteroid signaling pathway. Sci STKE 2006;2006:364.
Bostick M, Lochhead SR, Honda A, Palmer S, Callis J. Related to ubiquitin 1 and 2 are redundant and
essential and regulate vegetative growth, auxin signaling, and ethylene production in Arabidopsis.
Plant Cell 2004;16:2418–2432. [PubMed: 15319484]
Cano-Delgado A, Yin Y, Yu C, Vafeados D, Mora-Garcia S, Cheng JC, Nam KH, Li J, Chory J. BRL1
and BRL3 are novel brassinosteroid receptors that function in vascular differentiation in Arabidopsis.
Development 2004;131:5341–5351. [PubMed: 15486337]
Cary AJ, Liu W, Howell SH. Cytokinin action is coupled to ethylene in its effects on the inhibition of
root and hypocotyl elongation in Arabidopsis thaliana seedlings. Plant Physiol 1995;107:1075–1082.
[PubMed: 7770519]
Chae HS, Kieber JJ. Eto Brute? The role of ACS turnover in regulating ethylene biosynthesis. Trends
Plant Sci 2005;10:291–296. [PubMed: 15949763]
Chae HS, Faure F, Kieber JJ. The eto1, eto2 and eto3 mutations and cytokinin treatment elevate ethylene
biosynthesis in Arabidopsis by increasing the stability of the ACS5 protein. Plant Cell 2003;15:545–
559. [PubMed: 12566591]
Hansen et al. Page 8













Christians M, Gingerich D, Hansen M, Binder B, Kieber JJ, Vierstra RD. The BTB ubiquitin ligases
ETO1, EOL1, and EOL2 act collectively to regulate ethylene biosynthesis in Arabidopsis by
controlling type-2 ACC synthase levels. Plant J. 2008 doi: 10.1111/j.1365-313X.2008.03693.x, in
press.
Clough SJ, Bent AF. Floral dip: a simplified method for Agrobacterium-mediated transformation of
Arabidopsis thaliana. Plant J 1998;16:735–743. [PubMed: 10069079]
De Grauwe L, Vandenbussche F, Tietz O, Palme K, Van Der Straeten D. Auxin, ethylene and
brassinosteroids: tripartite control of growth in the Arabidopsis hypocotyl. Plant Cell Physiol
2005;46:827–836. [PubMed: 15851402]
Fujioka S, Yokota T. Biosynthesis and metabolism of brassinosteroids. Annu. Rev. Plant Biol
2003;54:137–164. [PubMed: 14502988]
Gingerich DJ, Gagne JM, Salter DW, Hellmann H, Estelle M, Ma L, Vierstra RD. Cullins 3a and 3b
assemble with members of the broad complex/tramtrack/bric-a-brac (BTB) protein family to form
essential ubiquitin-protein ligases (E3s) in Arabidopsis. J. Biol. Chem 2005;280:18810–18821.
[PubMed: 15749712]
Guzman P, Ecker JR. Exploiting the triple response of Arabidopsis to identify ethylene-related mutants.
Plant Cell 1990;2:513–523. [PubMed: 2152173]
Hutchison CE, Li J, Argueso C, et al. The Arabidopsis histidine phosphotransfer proteins are redundant
positive regulators of cytokinin signaling. Plant Cell 2006;18:3073–3087. [PubMed: 17122069]
Joo S, Liu Y, Lueth A, Zhang S. MAPK phosphorylation-induced stabilization of ACS6 protein is
mediated by the non-catalytic C-terminal domain, which also contains the cis-determinant for rapid
degradation by the 26S proteasome pathway. Plant J 2008;54:129–140. [PubMed: 18182027]
Kakimoto T. Perception and signal transduction of cytokinins. Annu. Rev. Plant Biol 2003;54:605–627.
[PubMed: 14503005]
Larsen PB, Cancel JD. A recessive mutation in the RUB1-conjugating enzyme, RCE1, reveals a
requirement for RUB modification for control of ethylene biosynthesis and proper induction of basic
chitinase and PDF1.2 in Arabidopsis. Plant J 2004;38:626–638. [PubMed: 15125769]
Li J. Brassinosteroids signal through two receptor-like kinases. Curr. Opin. Plant Biol 2003;6:494–499.
[PubMed: 12972051]
Li J, Jin H. Regulation of brassinosteroid signaling. Trends Plant Sci 2007;12:37–41. [PubMed:
17142084]
Liang X, Abel S, Keller JA, Shen NF, Theologis A. The 1-aminocyclopropane-1-carboxylate synthase
gene family of Arabidopsis thaliana. Proc. Natl Acad. Sci. U.S.A 1992;89:11046–11050. [PubMed:
1438312]
Liu Y, Zhang S. Phosphorylation of ACC synthase by MPK6, a stress-responsive MAPK, induces
ethylene biosynthesis in Arabidopsis. Plant Cell 2004;16:3386–3399. [PubMed: 15539472]
Mason MG, Li J, Mathews DE, Kieber JJ, Schaller GE. Type-B response regulators display overlapping
but distinct expression patterns in Arabidopsis. Plant Physiol 2004;135:927–937. [PubMed:
15173562]
Mason MG, Mathews DE, Argyros DA, Maxwell BB, Kieber JJ, Alonso JM, Ecker JR, Schaller GE.
Multiple type-B response regulators mediate cytokinin signal transduction in Arabidopsis. Plant Cell
2005;17:3007–3018. [PubMed: 16227453]
Pintard L, Willems A, Peter M. Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family.
EMBO J 2004;23:1681–1687. [PubMed: 15071497]
Rashotte AM, Carson SDB, To JPC, Kieber JJ. Expression profiling of cytokinin action in Arabidopsis.
Plant Physiol 2003;123:184–194.
Rashotte AM, Mason MG, Hutchison CE, Ferreira FJ, Schaller GE, Kieber JJ. A subset of Arabidopsis
AP2 transcription factors mediates cytokinin responses in concert with a two-component pathway.
Proc. Natl Acad. Sci. U.S.A 2006;103:11081–11085. [PubMed: 16832061]
Sebastià CH, Hardin SC, Clouse SD, Kieber JJ, Huber SC. Identification of a new motif for CDPK
phosphorylation in vitro that suggests ACC synthase may be a CDPK substrate. Arch. Biochem.
Biophys 2004;428:81–91. [PubMed: 15234272]
Hansen et al. Page 9













Spanu P, Grosskopf DG, Felix G, Boller T. The apparent turnover of 1-aminocyclopropane-1-carboxylate
synthase in tomato cells is regulated by protein phosphorylation and dephosphorylation. Plant Physiol
1994;106:529–535. [PubMed: 12232347]
Tatsuki M, Mori H. Phosphorylation of tomato 1-aminocyclopropane-1-carboxylic acid synthase, LE-
ACS2, at the C-terminal region. J. Biol. Chem 2001;276:28051–28057. [PubMed: 11375393]
To JPC, Kieber JJ. Cytokinin signaling: two-components and more. Trends Plant Sci 2008;13:85–92.
[PubMed: 18262459]
To JPC, Haberer G, Ferreira FJ, Deruère J, Mason MG, Schaller GE, Alonso JM, Ecker JR, Kieber JJ.
Type-A ARRs are partially redundant negative regulators of cytokinin signaling in Arabidopsis. Plant
Cell 2004;16:658–671. [PubMed: 14973166]
Tsuchisaka A, Theologis A. Heterodimeric interactions among the 1-amino-cyclopropane-1-carboxylate
synthase polypeptides encoded by the Arabidopsis gene family. Proc. Natl Acad. Sci. U.S.A 2004a;
101:2275–2280. [PubMed: 14983000]
Tsuchisaka A, Theologis A. Unique and overlapping expression patterns among the Arabidopsis 1-amino-
cyclopropane-1-carboxylate synthase gene family members. Plant Physiol 2004b;136:2982–3000.
[PubMed: 15466221]
Vogel JP, Schuerman P, Woeste KW, Brandstatter I, Kieber JJ. Isolation and characterization of
Arabidopsis mutants defective in induction of ethylene biosynthesis by cytokinin. Genetics 1998a;
149:417–427. [PubMed: 9584113]
Vogel JP, Woeste KW, Theologis A, Kieber JJ. Recessive and dominant mutations in the ethylene
biosynthetic gene ACS5 of Arabidopsis confer cytokinin insensitivity and ethylene overproduction,
respectively. Proc. Natl Acad. Sci. U.S.A 1998b;95:4766–4771. [PubMed: 9539813]
Wang KL-C, Yoshida H, Lurin C, Ecker JR. Regulation of ethylene gas biosynthesis by the Arabidopsis
ETO1 protein. Nature 2004;428:945–950. [PubMed: 15118728]
Wang N, Shih M, Li N. The GUS reporter-aided analysis of the promoter activities of Arabidopsis ACC
synthase genes AtACS4, AtACS5, and AtACS7 induced by hormones and stresses. J. Exp. Bot
2005;56:909–920. [PubMed: 15699063]
Weber H, Bernhardt A, Dieterle M, Hano P, Mutlu A, Estelle M, Genschik P, Hellmann H. Arabidopsis
AtCUL3a and AtCUL3b form complexes with members of the BTB/POZMATH protein family.
Plant Physiol 2004;137:83–93. [PubMed: 15618422]
Woeste K, Vogel JP, Kieber JJ. Factors regulating ethylene biosynthesis in etiolated Arabidopsis
thaliana seedlings. Physiol. Plant 1999a;105:478–484.
Woeste K, Ye C, Kieber JJ. Two Arabidopsis mutants that overproduce ethylene are affected in the post-
transcriptional regulation of ACC synthase. Plant Physiol 1999b;119:521–530. [PubMed: 9952448]
Woodward AW, Ratzel SE, Woodward EE, Shamoo Y, Bartel B. Mutation of E1-CONJUGATING
ENZYME-RELATED1 decreases RELATED TO UBIQUITIN conjugation and alters auxin
response and development. Plant Physiol 2007;144:976–987. [PubMed: 17449645]
Yamagami T, Tsuchisaka A, Yamada K, Haddon WF, Harden LA, Theologis A. Biochemical diversity
among the 1-amino-cyclopropane-1-carboxylate synthase isozymes encoded by the Arabidopsis gene
family. J. Biol. Chem 2003;278:49102–49112. [PubMed: 12968022]
Yang SF, Hoffman NE. Ethylene biosynthesis and its regulation in higher plants. Annu. Rev. Plant Physiol
1984;35:155–189.
Yi HC, Joo S, Nam KH, Lee JS, Kang BG, Kim WT. Auxin and brassinosteroid differentially regulate
the expression of the three members of the 1-aminocyclopropane-1-carboxylate synthase family in
mung bean (Vigna radiata L.). Plant Mol. Biol 1999;41:443–454. [PubMed: 10608655]
Yoshida H, Nagata M, Saito K, Ecker J. Arabidopsis ETO1 specifically interacts with and negatively
regulates type 2 1-aminocyclopropane-1-carboxylate synthases. BMC Plant Biol 2005;5:14.
[PubMed: 16091151]
Yoshida H, Wang KLC, Chang CM, Mori K, Uchida E, Ecker JR. The ACC synthase TOE sequence is
required for interaction with ETO1 family proteins and destabilization of target proteins. Plant Mol.
Biol 2006;62:427–437. [PubMed: 16897471]
Zhou A, Wang H, Walker JC, Li J. BRL1, a leucine-rich repeat receptor-like protein kinase, is functionally
redundant with BRI1 in regulating Arabidopsis brassinosteroid signaling. Plant J 2004;40:399–409.
[PubMed: 15469497]
Hansen et al. Page 10













Zimmermann P, Hirsch-Hoffmann M, Hennig L, Gruissem W. GENEVESTIGATOR. Arabidopsis
microarray database and analysis toolbox. Plant Physiol 2004;136:2621–2632. [PubMed: 15375207]
Hansen et al. Page 11













Figure 1. Morphology of four-day-old etiolated seedlings
Wild-type and ein2−5 seedlings were grown on MS with control carrier, 1 μM ACC, 5 μM BA
or 0.1 μM BR. Three representative seedlings of each genotype and treatment are shown.
Seedlings treated with BR were flattened to keep the entire seedling in focus. Scale bar = 1
mm.
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Figure 2. Ethylene production by four-day-old etiolated seedlings in response to BA and BR
(a) Ethylene produced over 4 days in wild-type seedlings treated with carrier control, 5 μM BA
or 0.5 μM BR.
(b) Ethylene produced by ahk receptor mutants in carrier control (black bars) or 5 μM BA
(shaded bars).
(c) Ethylene produced by ahp1,2,3 and ahp1,2,3,4 mutants in carrier control (black bars) or 5
μM BA (shaded bars).
(d) Ethylene produced by type B arr or crf mutants in response to carrier (black bars) or 5 μM
BA (shaded bars).
(e) Ethylene produced by wild-type (black circles and solid line) and the type A multiple mutant
arr3,4,5,6,8,9 (gray circles and dotted line) for a range of BA treatments.
For (a), ethylene was accumulated over 4 days; for (b)–(e), ethylene accumulation from day 3
to day 4 was determined. Error bars represent the standard error.
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Figure 3. myc–ACS5 protein levels are altered in response to BR and BA
(a) Western blot analysis of protein extracts from 4-day-old etiolated seedlings grown on either
carrier control or 0.1 μM BR and treated with cycloheximide for the time indicated. The blots
were stripped and then probed with an anti-β-tubulin antibody as a control. This image is
representative of five blots performed.
(b) Quantification of the protein level in (a). Open circles represent BR treatment; closed circles
represent treatment with the carrier control. Each band in (a) was quantified, normalized to its
relevant tubulin control, and plotted as a percentage of the time 0 control. The lines show the
best fit using an exponential equation: solid line, carrier treatment; dashed line, BR treatment.
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(c) Steady-state protein level of myc–ACS5 at various times after addition of 5 μM BA or a
carrier control.
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Figure 4. Steady-state levels of myc-tagged ACS proteins in response to BA and/or BR
Four-day-old etiolated seedlings harboring a Dex-inducible promoter expressing myc fusion
proteins myc–ACS5, myc–ACS5eto2, myc–ACS9 or myc–ACS9eto3 were grown on carrier
control, 5 μM BA, 0.1 μM BR, or 5 μM BA plus 0.1 μM BR as indicated. A representative blot
from three replicates is shown for each experiment.
Hansen et al. Page 16













Figure 5. Model of regulation of type 2 ACSs by BR and cytokinin
Cytokinin binds to AHK receptors, which auto-phosphorylate and subsequently transmit a
phosphoryl group to the AHPs. The AHPs can then phosphorylate type B or type A ARRs.
The type B ARR1, and perhaps other untested type B ARRs, act to prevent degradation of type
2 ACS, in a non-C-terminus-dependent manner. The type A ARRs negatively regulate ethylene
biosynthesis, and also cytokinin signaling. The blocking arrow denotes negative feedback on
cytokinin signaling, but not at a particular point in the cytokinin-signaling pathway. BR blocks
degradation of type 2 ACS, presumably through receptor BRI1. PM denotes the plasma
membrane; S in the ACS protein represents Ser461, a putative CDPK phosphorylation site.
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